<DOC>
	<DOCNO>NCT00600288</DOCNO>
	<brief_summary>The purpose pilot study evaluate effect diquafosol tetrasodium Ophthalmic Solution , 2 % dry eye subject .</brief_summary>
	<brief_title>Study Effect Diquafosol Tetrasodium Ophthalmic Solution , 2 % Versus Placebo Dry Eye Subjects ( P08634 )</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Provide write informed consent prior study procedure perform . Have best correct visual acuity ( BCVAof +0.7 well . Have history dry eye ( keratoconjunctivitis sicca ) eye Have ongoing dry eye disease , qualify eye eye . Have previously LASIK refractive surgery . Use topical ophthalmic medication , prep , gel lid scrub study . Have penetrate intraocular surgery past 90 day . Have ocular surface surgery ( e.g. , refractive , pterygium ) within past year . Have diagnosis ongoing ocular infection , clinically significant blepharitis , lid margin inflammation , StevensJohnson syndrome pemphigoid . Any serious ocular systemic disease uncontrolled medical condition . Exposure investigational drug within 30 day study start .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>